Thrombolysis
16
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
25%
4 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction（ELASTIC）
A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis
Thrombolysis in Early Acute Ischemic Stroke Trial-Blood Pressure Management
Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease
Endovascular Treatment With or Without Preceding Intravenous Tenecteplase (TNK) in Patients With Late-window acUte Ischemic Stroke Due to Middle Cerebral Artery Occlusion
Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT
Rescue Stenting and Intravenous Thrombolysis in Patients with Large Vessel Ischemic Stroke
Tenecteplase in Stroke Patients Between 4.5 and 24 Hours
Application of Standardized Green Channel Treatment System for Ischemic Stroke in Xi 'an
Prospective Study of Cerebrovascular Accidents (CVA) in 3 French Cities (Besançon, Cayenne and Tours)
Contemporary Endovascular Therapies in Treatment of Acute Iliofemoral Deep Vein Thrombosis
Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial Infarction
CaveoVasc Thrombolysis Protection System, Access Protection Study
Submassive Pulmonary Embolism Experience With EKOS
The Impact of a Helicopter Emergency Medical System on Prognosis in Stroke Patients
Hypothermia in Acute Ischemic Stroke - Surface Versus Endovascular Cooling (HAIS-SE)